Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Receptor Tyrosine Protein Kinase ERBB 4 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Receptor Tyrosine Protein Kinase ERBB 4market, defines the market attractiveness level of Receptor Tyrosine Protein Kinase ERBB 4 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Receptor Tyrosine Protein Kinase ERBB 4 industry, describes the types of Receptor Tyrosine Protein Kinase ERBB 4 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Receptor Tyrosine Protein Kinase ERBB 4 market and the development prospects and opportunities of Receptor Tyrosine Protein Kinase ERBB 4 industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Receptor Tyrosine Protein Kinase ERBB 4 market in Chapter 13.
By Player:
Hanmi Pharmaceuticals Co Ltd
XuanZhu Pharma Co Ltd
Aslan Pharmaceuticals Pte Ltd
Puma Biotechnology Inc
Minerva Neurosciences Inc
Zensun (Shanghai) Sci & Tech Co Ltd
GamaMabs Pharma SA
Pfizer Inc
Jiangsu Kanion Pharmaceutical Co Ltd
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Boehringer Ingelheim GmbH
By Type:
PB-357
NT-113
NRG-4
MIN-301
Others
By End-User:
Skin Cancer
Systolic Heart Failure
Neuroblastoma
Oligodendroglioma
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Receptor Tyrosine Protein Kinase ERBB 4 Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Receptor Tyrosine Protein Kinase ERBB 4 Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Receptor Tyrosine Protein Kinase ERBB 4 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Receptor Tyrosine Protein Kinase ERBB 4 Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Receptor Tyrosine Protein Kinase ERBB 4 Market Analysis and Outlook to 2022
-
7.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Consumption (2017-2022)
-
7.2 United States Receptor Tyrosine Protein Kinase ERBB 4 Consumption (2017-2022)
-
7.3 Europe Receptor Tyrosine Protein Kinase ERBB 4 Consumption (2017-2022)
-
7.4 China Receptor Tyrosine Protein Kinase ERBB 4 Consumption (2017-2022)
-
7.5 Japan Receptor Tyrosine Protein Kinase ERBB 4 Consumption (2017-2022)
-
7.6 India Receptor Tyrosine Protein Kinase ERBB 4 Consumption (2017-2022)
-
7.7 South Korea Receptor Tyrosine Protein Kinase ERBB 4 Consumption (2017-2022)
8 Region and Country-wise Receptor Tyrosine Protein Kinase ERBB 4 Market Analysis and Outlook to 2028
-
8.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast (2022-2028)
-
8.2 United States Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast (2022-2028)
-
8.3 Europe Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast (2022-2028)
-
8.4 China Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast (2022-2028)
-
8.5 Japan Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast (2022-2028)
-
8.6 India Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast (2022-2028)
-
8.7 South Korea Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast (2022-2028)
9 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Outlook by Types and Applications to 2022
-
9.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global PB-357 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global NT-113 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global NRG-4 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global MIN-301 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Skin Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Systolic Heart Failure Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Neuroblastoma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Oligodendroglioma Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Outlook by Types and Applications to 2028
-
10.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global PB-357 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global NT-113 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global NRG-4 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global MIN-301 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Skin Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Systolic Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Neuroblastoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Oligodendroglioma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Receptor Tyrosine Protein Kinase ERBB 4 Import and Export Analysis (Top 5 Countries)
-
11.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Receptor Tyrosine Protein Kinase ERBB 4 Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Competitive Analysis
-
14.1 Hanmi Pharmaceuticals Co Ltd
-
14.1.1 Hanmi Pharmaceuticals Co Ltd Company Details
-
14.1.2 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
14.2 XuanZhu Pharma Co Ltd
-
14.2.1 XuanZhu Pharma Co Ltd Company Details
-
14.2.2 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
14.3 Aslan Pharmaceuticals Pte Ltd
-
14.3.1 Aslan Pharmaceuticals Pte Ltd Company Details
-
14.3.2 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
14.4 Puma Biotechnology Inc
-
14.4.1 Puma Biotechnology Inc Company Details
-
14.4.2 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
14.5 Minerva Neurosciences Inc
-
14.5.1 Minerva Neurosciences Inc Company Details
-
14.5.2 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
14.6 Zensun (Shanghai) Sci & Tech Co Ltd
-
14.6.1 Zensun (Shanghai) Sci & Tech Co Ltd Company Details
-
14.6.2 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
14.7 GamaMabs Pharma SA
-
14.7.1 GamaMabs Pharma SA Company Details
-
14.7.2 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
14.8 Pfizer Inc
-
14.8.1 Pfizer Inc Company Details
-
14.8.2 Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
14.9 Jiangsu Kanion Pharmaceutical Co Ltd
-
14.9.1 Jiangsu Kanion Pharmaceutical Co Ltd Company Details
-
14.9.2 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
14.10 Shanghai Fosun Pharmaceutical (Group) Co Ltd
-
14.10.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Details
-
14.10.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
14.11 Boehringer Ingelheim GmbH
-
14.11.1 Boehringer Ingelheim GmbH Company Details
-
14.11.2 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Receptor Tyrosine Protein Kinase ERBB 4
-
Figure Receptor Tyrosine Protein Kinase ERBB 4 Picture
-
Table Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Receptor Tyrosine Protein Kinase ERBB 4 Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Receptor Tyrosine Protein Kinase ERBB 4 Consumption by Country (2017-2022)
-
Figure United States Receptor Tyrosine Protein Kinase ERBB 4 Consumption and Growth Rate (2017-2022)
-
Table Europe Receptor Tyrosine Protein Kinase ERBB 4 Consumption and Growth Rate (2017-2022)
-
Figure China Receptor Tyrosine Protein Kinase ERBB 4 Consumption and Growth Rate (2017-2022)
-
Figure Japan Receptor Tyrosine Protein Kinase ERBB 4 Consumption and Growth Rate (2017-2022)
-
Figure India Receptor Tyrosine Protein Kinase ERBB 4 Consumption and Growth Rate (2017-2022)
-
Figure South Korea Receptor Tyrosine Protein Kinase ERBB 4 Consumption and Growth Rate (2017-2022)
-
Figure Global Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast by Country (2022-2028)
-
Figure United States Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Receptor Tyrosine Protein Kinase ERBB 4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PB-357 Consumption and Growth Rate (2017-2022)
-
Figure Global NT-113 Consumption and Growth Rate (2017-2022)
-
Figure Global NRG-4 Consumption and Growth Rate (2017-2022)
-
Figure Global MIN-301 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Skin Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Systolic Heart Failure Consumption and Growth Rate (2017-2022)
-
Figure Global Neuroblastoma Consumption and Growth Rate (2017-2022)
-
Figure Global Oligodendroglioma Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global PB-357 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NT-113 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NRG-4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MIN-301 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Skin Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Systolic Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neuroblastoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oligodendroglioma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Receptor Tyrosine Protein Kinase ERBB 4 Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Receptor Tyrosine Protein Kinase ERBB 4 Export by Region (Top 5 Countries) (2017-2028)
-
Table Hanmi Pharmaceuticals Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
Table XuanZhu Pharma Co Ltd (Foundation Year, Company Profile and etc.)
-
Table XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
Table Aslan Pharmaceuticals Pte Ltd (Foundation Year, Company Profile and etc.)
-
Table Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
Table Puma Biotechnology Inc (Foundation Year, Company Profile and etc.)
-
Table Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
Table Minerva Neurosciences Inc (Foundation Year, Company Profile and etc.)
-
Table Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
Table Zensun (Shanghai) Sci & Tech Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
Table GamaMabs Pharma SA (Foundation Year, Company Profile and etc.)
-
Table GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
Table Jiangsu Kanion Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
Table Shanghai Fosun Pharmaceutical (Group) Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Product and Service
-
